#Merck
2 articles with this tag
HealthModerna and Merck's Breakthrough Melanoma Vaccine Revives Promise for mRNA Technology
A late-stage trial by Moderna and Merck shows their personalised mRNA melanoma vaccine successfully reduces cancer recurrence when combined with Keytruda, marking a major milestone for the technology.
The National|August 20, 2026
HealthModerna and Merck Announce Breakthrough mRNA Cancer Vaccine That Significantly Reduces Melanoma Spread
Moderna and Merck revealed that their personalised mRNA cancer vaccine, Intismeran, successfully reduced the recurrence and spread of high-risk melanoma in a late-stage clinical trial.
Al Jazeera English|August 19, 2026